Asparaginase
Elspar, Spectrila (asparaginase) is an enzyme pharmaceutical. Asparaginase was first approved as Elspar on 1978-01-10. It is used to treat cholelithiasis, lymphoma, and precursor cell lymphoblastic leukemia-lymphoma in the USA. It has been approved in Europe to treat precursor cell lymphoblastic leukemia-lymphoma.
Trade Name | Spectrila |
---|---|
Common Name | Asparaginase |
Indication | cholelithiasis, lymphoma, precursor cell lymphoblastic leukemia-lymphoma |
Drug Class | Enzymes |
